These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 12720131

  • 1. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
    Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M, Hematology/Oncology Studies and Trials (HOST) Group, Italy.
    Semin Oncol; 2003 Apr; 30(2):172-7. PubMed ID: 12720131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
    Cesana C, Miqueleiz S, Bernuzzi P, Tresoldi E, Rossi V, D'avanzo G, Filippini D, Morra E.
    Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.
    J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113
    [Abstract] [Full Text] [Related]

  • 5. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E.
    Semin Oncol; 2003 Apr 15; 30(2):178-81. PubMed ID: 12720132
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ.
    Semin Oncol; 2003 Apr 15; 30(2):169-71. PubMed ID: 12720130
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P.
    J Clin Oncol; 2005 Jul 20; 23(21):4662-8. PubMed ID: 16034042
    [Abstract] [Full Text] [Related]

  • 8. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ.
    N Engl J Med; 2002 Feb 21; 346(8):564-9. PubMed ID: 11856795
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics and outcome of immunoglobulin M-related disorders.
    Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M, Filippini D, Lazzarino M, Morra E.
    Clin Lymphoma; 2005 Mar 21; 5(4):261-4. PubMed ID: 15794861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ.
    Blood; 2003 Nov 15; 102(10):3759-64. PubMed ID: 12881316
    [Abstract] [Full Text] [Related]

  • 13. Asymptomatic Waldenstrom's macroglobulinemia.
    Alexanian R, Weber D, Delasalle K, Cabanillas F, Dimopoulos M.
    Semin Oncol; 2003 Apr 15; 30(2):206-10. PubMed ID: 12720137
    [Abstract] [Full Text] [Related]

  • 14. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Gobbi PG, Baldini L, Broglia C, Goldaniga M, Comelli M, Morel P, Morra E, Cortelazzo S, Bettini R, Merlini G.
    Clin Cancer Res; 2005 Mar 01; 11(5):1786-90. PubMed ID: 15756000
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of a population based cohort with monoclonal proteinaemia.
    Schaar CG, le Cessie S, Snijder S, Franck PF, Wijermans PW, Ong C, Kluin-Nelemans H.
    Br J Haematol; 2009 Jan 01; 144(2):176-84. PubMed ID: 19036113
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
    Rossi F, Petrucci MT, Guffanti A, Marcheselli L, Rossi D, Callea V, Vincenzo F, De Muro M, Baraldi A, Villani O, Musto P, Bacigalupo A, Gaidano G, Avvisati G, Goldaniga M, Depaoli L, Baldini L.
    Clin Cancer Res; 2009 Jul 01; 15(13):4439-45. PubMed ID: 19509142
    [Abstract] [Full Text] [Related]

  • 18. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 01; 11(1):74-6. PubMed ID: 21454195
    [Abstract] [Full Text] [Related]

  • 19. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
    Gertz MA, Kyle RA, Noel P.
    J Clin Oncol; 1993 May 01; 11(5):914-20. PubMed ID: 8487054
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.